YYYingxin Yu

Yingxin Yu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yingxin Yu has a total of 20 co-authors. Here are the top co-authors by number of shared publications:

  • Xiaokun Qi

    Department of Neurology, The Second affiliated Hospital, Anhui Medical University, Hefei, China

    3 shared publications
  • Yimo Zhang

    Department of Neurology, First Medical Center of Chinese People's Liberation Army (PLA) General Hospital, Beijing, China

    3 shared publications
  • Zhiwei Wang

    Department of Neurology, The First Medical Center, Chinese PLA General Hospital, Beijing, China

    3 shared publications
  • Bo Zhao

    From the Department of Neurology (B.Z., Y.Z., X.Q., Y.Y.), The First Medical Center, Chinese PLA General Hospital, Beijing; The Second School of Clinical Medicine (B.Z., M.Y., S.P.), Southern Medical University, Guangzhou; Department of Hyperbaric Oxygen (B.Z., H.L., S.P.), and Department of Emergency (Z.Z.), Sixth Medical Center of Chinese PLA General Hospital; and Department of Neurology (J.Z.), The 305th Hospital of the People's Liberation Army, Beijing, China

    2 shared publications
  • Miao Yang

    From the Department of Neurology (B.Z., Y.Z., X.Q., Y.Y.), The First Medical Center, Chinese PLA General Hospital, Beijing; The Second School of Clinical Medicine (B.Z., M.Y., S.P.), Southern Medical University, Guangzhou; Department of Hyperbaric Oxygen (B.Z., H.L., S.P.), and Department of Emergency (Z.Z.), Sixth Medical Center of Chinese PLA General Hospital; and Department of Neurology (J.Z.), The 305th Hospital of the People's Liberation Army, Beijing, China

    2 shared publications
  • Ming Ren

    Department of Neurology, Shanghai Blue Cross Brain Hospital, Shanghai, China

    2 shared publications

Latest Publications

  • Open Access

    Autoimmune glial fibrillary acidic protein astrocytopathy misdiagnosed as intracranial infectious diseases: case reports and literature review

    by Runhua Bai, Li An, Wei Du, Zhiwei Wang, Xiaokun Qi, Jianguo Liu, Ming Ren, Yingxin Yu

    Background: Autoimmune glial fibrillary acidic protein astrocytopathy (A-GFAP-A) is an autoimmune central nervous system(CNS) disease characterized by GFAP IgG as a biomarker. Several cases of individuals with A-GFAP-A initially misdiagnosed as infectious diseases of the central nervous system have been reported in research. We report three cases of A-GFAP-A misdiagnosed as viral meningitis or tuberculous meningitis (TBM). We summarize recent cases of A-GFAP-A misdiagnosed as central nervous system infections through a literature review.Materials and methods: Three cases of A-GFAP-A were initially misdiagnosed as tuberculous or viral meningitis. Their diagnoses of A-GFAP-A were confirmed with positive GFAP-IgG in cerebrospinal fluid (CSF). We searched the PubMed database with the key words of “GFAP astrocytopathy”, “GFAP autoimmunity”, “GFAP autoantibody”, “intracranial infection”, “meningitis”, “misdiagnose”, and within the literature from Jan 1, 2015 to Mar 15, 2024, 40 cases with A-GFAP-A with positive GFAP-IgG in CSF who were previously misdiagnosed with intracranial infection were reported. The causes of misdiagnoses were summarized and analyzed.Results: Case 1 was a 41-year-old female, presenting with headache, fever, diplopia, and altered consciousness level. Anti-tuberculosis treatment was ineffective. Finally, with positive GFAP IgG in CSF, she was diagnosed with A-GFAP-A. Case 2 was a 74-year-old male, presenting with fever, excessive sweating, fatigue, and memory loss. Anti-tuberculosis treatment was ineffective. With positive GFAP IgG in CSF, he was diagnosed with A-GFAP-A. Case 3 was a 54-year-old male, presenting with fever, personality changes, and memory decline. Antiviral treatment was ineffective. His diagnosis was revised to A-GFAP-A after testing positive for GFAP IgG in CSF. Our study summarized a total of 40 patients with A-GFAP-A who were initially misdiagnosed as intracranial infections. The most common clinical phenotypes among 40 patients were mimicked meningitis, meningoencephalitis, meningoencephalomyelitis, encephalitis and encephalomyelitis.Conclusion: A-GFAP-A is a specific autoimmune meningoencephalomyelitis associated with GFAP-IgG, with lesions involved the brain, meninges, and spinal cord. It commonly presents with symptoms such as fever, headache, altered consciousness, tremor, seizures, and autonomic dysfunction. Brain MRI often shows characteristic linear perivascular radial enhancement perpendicular to the ventricles or nonspecific leptomeningeal enhancement. Early detection of GFAP-IgG in serum and CSF is essential for differential diagnosis.


  • Open Access

    Clinical and neuroimaging characteristics of diabetic striatopathy: a case series report

    by Yaning Chen, Chunliu Wu, Ming Ren, Qingjun Wang, Zhiwei Wang, Yimo Zhang, Yingxin Yu

    Background: Diabetic striatopathy (DS) is a rare disorder characterized by clinical manifestations of hemichorea, non-ketotic hyperglycemia, and high signal on T1-weighted MRI or high density on CT scan in basal ganglia, typically associated with poor glycemic control.Objective: This study aimed to analyze clinical characteristics of patients with diabetic striatopathy to raise awareness amongst physicians, especially endocrinologists, about this rare neurological manifestation in patients with diabetes.Methods: We retrospectively analyzed the data on clinical presentations, laboratory workups, and cranial CT and MRI of six patients with DS who were admitted to our hospital from October 2013 to June 2022.Results: The mean age of onset among the six patients was 80.5 years, and the mean value of HbA1c was 13.65%. All six patients complained of involuntary movements, which primarily affected the arm and leg on one side of the body. Bilateral caudate nucleus hyperdensities were shown on the CT examination in Case 3,while the other 5 patients, unilateral caudate nucleus hyperdensity was shown. In addition, five patients (except Case 5) underwent MRI, all showing hypersignal lesions on the T1-weighted images. A low signal in the right basal ganglia was shown on MRI susceptibility weighted imaging (SWI) sequences in Case 6. All six patients exhibited carotid artery or cerebral artery stenosis. Following strict blood glucose control and symptomatic management, the symptoms of chorea improved significantly in all patients, and repeat images indicated that the lesions gradually disappeared.Conclusion: Both poor vascular conditions and severe hyperglycemia contribute to the development of diabetic striatopathy. The prognosis is usually good by active treatment.


  • Clinical Reasoning: A 17-Year-Old Girl With Progressive Cognitive Impairment

    by Bo Zhao, Zonghong Zhu, Jinjing Zhao, Miao Yang, Yimo Zhang, Hang Li, Shuyi Pan, Xiaokun Qi, Yingxin Yu

    A 17-year-old girl presented with a long history of cognitive impairment, personality and behavioral changes, dysarthria, and paroxysmal lower-extremity weakness. She was initially suspected of having mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS) because of stroke-like symptoms, such as episodic lower extremity weakness, as well as abnormal brain MRI findings of generalized cerebral atrophy, extensive high intensity lesions in the cortex and subcortical white matter on FLAIR images, decreased N-acetyl aspartate (NAA)/creatine (Cr) ratio, and a lactate peak in the focal area on spectrum images. However, there were no relatives with similar presentations in the family of the patient. The whole mitochondrial genome and whole exome sequencing did not suggest pathogenic mutations, and no abnormalities were found in the blood or cerebrospinal fluid lactate levels. In this case, we detail the clinical manifestations, diagnostic workup, and imaging findings. This case highlights the importance of the assessment of cognitive function and the relevant differential diagnoses in an adolescent with cognitive impairment.

  • Open Access

    Clinical characteristics of two patients with neuronal intranuclear inclusion disease and literature review

    by Bo Zhao, Miao Yang, Zhiwei Wang, Qiqiong Yang, Yimo Zhang, Xiaokun Qi, Shuyi Pan, Yingxin Yu

    Background: Neuronal intranuclear inclusion disease (NIID) is a rare chronic progressive neurodegenerative disease, with complex and diverse clinical manifestations and pathological eosinophilic hyaline intranuclear inclusions in the central and peripheral nervous systems and visceral organs. Improvements in diagnostic methods such as skin biopsy and gene testing are helpful in revealing the clinical and genetic characters of NIID.Materials and methods: We presented two cases of NIID diagnosed by using NOTCH2NLC gene testing and skin biopsy. Diffusion weighted imaging (DWI) showed high linear intensity in corticomedullary junction. We also reviewed all the published NIID cases with positive NOTCH2NLC GGC repeat expansion and skin biopsy results in PubMed.Results: Patient 1 was a 63-year-old male who carried 148 GGC repeats and presented with progressive tremor and limb weakness. Patient 2 was a 62-year-old woman who carried 131 GGC repeats and presented with tremors, memory loss and headaches. The most common clinical manifestation of 63 NIID patients in this study was cognitive impairment, followed by tremors. In our study, almost all the patients were from East Asia, the male to female ratio was 1:1.26, with an age of onset of 54.12 ± 14.12 years, and an age of diagnosis of 60.03 ± 12.21 years. Symmetrical high signal intensity at the corticomedullary junction on DWI were revealed in 80.96% of the patients. For the GGC repeat numbers, the majority of GGC repeats were in the 80–119 intervals, with few GGC repeats above 160. The number of GGC repetitions was significantly higher in patients presented with muscle weakness than in other clinical manifestations.Conclusion: NIID is a neurodegenerative disease caused by aberrant polyglycine (polyG) protein aggregation. NIID mostly occurs in the elderly population in East Asia, with cognitive dysfunction as the most common symptom. Staging NIID based on clinical presentation is inappropriate because most patients with NIID have overlapping symptoms. In our study, there was no significant correlation between the number of GGC repeats and different phenotypes except for muscle weakness. Abnormal trinucleotides repeat and PolyG protein aggregation maybe common pathogenic mechanism in neurodegenerative diseases and cerebrovascular diseases, which needs to be confirmed by more studies.


  • Open Access

    Anti‐PrP monoclonal antibody as a novel treatment for neurogenesis in mouse model of Alzheimer's disease

    by Ruolin Li, Ming Ren, Yingxin Yu

    Background: Alzheimer's disease (AD) is the most common degenerative disease characterized by cognitive impairment, memory decline, and language disorder for which there is no effective treatment. Neurogenesis has been indicated in AD and may play an important role in the pathogenesis of AD. Targeting this pathway is a new idea for the treatment of the disease. A recent study reveals that the cellular prion protein (PrP), a receptor for Aβ oligomers, regulates neurogenesis, and its elevated expression is related to cell differentiation. The aim of the present study was to investigate the neuroprotective effects of 6D11 (PrP monoclonal antibody) via neurogenesis promotion in APP/PS1 transgenic mice and Aβ‐induced cell model of AD.Methods: In the present study, 9‐month‐old male APP/PS1 mice were injected with 6D11. Then, the Morris water maze was used to examine the spatial learning and memory abilities of the mice in both groups, and immunostained was used to assess the level of Aβ, neurogenesis, and neural stem cells (NSCs) differentiation.Results: 6D11 attenuated cognitive deficits in APP/PS1 transgenic mice, which was accompanied by a decrease of the deposition of Aβ. In addition, 6D11 treatment promoted differentiation of the existing hippocampal cells to neurons.Conclusions: Our findings confirmed that 6D11 has a therapeutic effect in APP/PS1 transgenic AD mouse model and Aβ‐induced AD cell model, and the effect exerted via increase of neurogenesis and cell differentiation by transduction of Aβ peptide signal.


  • A case of progressive multifocal leukoencephalopathy with HIV positivity

    by Yingxin Yu

    Background: We report a case of progressive multifocal leukoencephalopathy with HIV positive. We analyzed her epidemiology, clinical manifestation, neuroimaging and laboratory test.Method: The patient was a 36‐year‐old right‐handed man with 4 months of left upper limb numb, 2 months of left limbs weak. 4 months ago, he felt cold on her left upper limb without any reason.3 months agohe suddenly couldn’t recognize his routine home way for several minutes. 2 months ago, he felt dizzy and weak on his left upper limb. He was considered as cervical spondylosis without recover after massage. His brain MRI showed his right frontal and parietal cortex ischemic, right thalamus, corona radiata and callosum ischemic infarction (subacute stage), and posterior angel of bilateral ventricles demyelination. The focus weren’t enhanced on brain enhancement MRI. He got treatment according to cerebral infarction and didn’t relieve. His blood test results showed decreased white cells, red cells and platelet count. His CSF test was normal. His serum NMDA, AQP4 antibody were all negative.1 months ago, he began to have fever and could relieve after cortisone. He couldn’t get better after antiviral therapy according to viral encephalitis. His bilateral vision suddenly got blind. His PET‐CT scan was normal. He didn’t relieve after immune globulin. His nervous system examination showed his cognitive function deceased, left central facial paralysis and left limbs upper motor neuron paralysis. His bilateral light reflex was normal. However both of his eyes couldn’t react on light. His bone marrow aspiration was normal. Finally, he got HIV test and the result was positive. His CSF and urine of JC virus PCR test were 1000000copies/ml and 2000copies/ml.Result: He was diagnosed as progressive multifocal leukoencephalopathy and HIV infection. 1 month later, he was dead.Conclusion: The syndromes of this case became worse and worse, but he couldn’t get right diagnose and treatment. His brain MRI image seems like ischemic stroke. The most important HIV test was done at the final stage. This case gave us a lesson and we should keep mind on HIV test.